News
Healthcare and pharma companies like Dr Reddy's Laboratories, Laurus Labs Ltd, Alembic Pharmaceuticals Ltd and Sun Pharma are ...
A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.
The market needs to reclaim and sustain above the 20-day EMA to witness a further northward journey in the upcoming sessions.
4h
Capital Market on MSNSun Pharma launches Leqselvi in US; settles litigation with Incyte CorpThe drug is indicated for the treatment of alopecia areata - a condition in which the immune system attacks hair follicles, ...
Hero MotoCorp Ltd led the Nifty 50 gainers with a 4 per cent surge after unveiling its global expansion strategy, while HCL ...
Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...
Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for ...
From the Sensex firms, Sun Pharma, Bajaj Finserv, Trent, Tata Motors and Mahindra & Mahindra were among the gainers, with Sun ...
HeroMotoCorp shares led gains, rising 4.76%. Bajaj Auto and Sun Pharma closed 2.76% and 2.67% up, respectively.
LinkedIn’s Cities on the Rise 2025 report spotlights India’s fastest-growing job markets beyond metros. Tier 2 and 3 cities ...
LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...
India VIX, the fear gauge, eased 3 percent which suggests that there are little-to-no signs of panic-driven exits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results